Mount Sinai, MSK researchers create AI tool to predict immunotherapy outcomes

Becker's Healthcare January 7, 2025
Erica Carbajal

Determining which cancer patients are a good candidate for immune checkpoint inhibitors can be a challenge, but researchers at Mount Sinai and Memorial Sloan Kettering Cancer Center have developed a promising tool to predict which patients will respond well to the therapy.

The tool, an artificial intelligence-based model called SCORPIO, uses routine blood tests to predict treatment success. Researchers developed and validated the model based on data from nearly 10,000 patients across 21 cancer types. It is the first tool capable of predicting patients’ response to immune checkpoint inhibitors based on basic clinical data, according to the researchers. The study, which was published in Nature Medicine, also found the tool’s predictive ability was better than FDA-approved biomarkers.

Immune...

Today's Sponsors

Today's Sponsor